PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like particle vaccine candidate, by cloning and transf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazumder, Saumyabrata, Rastogi, Ruchir, Undale, Avinash, Arora, Kajal, Arora, Nupur Mehrotra, Pratim, Biswa, Kumar, Dilip, Joseph, Abyson, Mali, Bhupesh, Arya, Vidya Bhushan, Kalyanaraman, Sriganesh, Mukherjee, Abhishek, Gupta, Aditi, Potdar, Swaroop, Roy, Sourav Singha, Parashar, Deepak, Paliwal, Jeny, Singh, Sudhir Kumar, Naqvi, Aelia, Srivastava, Apoorva, Singh, Manglesh Kumar, Kumar, Devanand, Bansal, Sarthi, Rautray, Satabdi, Saini, Manish, Jain, Kshipra, Gupta, Reeshu, Kundu, Prabuddha Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487870/
https://www.ncbi.nlm.nih.gov/pubmed/34632131
http://dx.doi.org/10.1016/j.heliyon.2021.e08124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487870/
https://www.ncbi.nlm.nih.gov/pubmed/34632131
http://dx.doi.org/10.1016/j.heliyon.2021.e08124

Ejemplares similares